← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $4.7M of United Therapeutics Corporation

Sold$4,689,051
$564.95Price
8,300Shares
−16%Stake

What UTHR did after the filing

Filed Oct 1Copier in Oct 2
The stock from Fri, Oct 2 open, $570.00
−4.7%
S&P 500, same days
−0.5%

11 of 30 trading days so far, to the Oct 19 close.

Traded Thu, Oct 1. Filed Thu, Oct 1, 5:30 PM ET, after the close. Returns use the Oct 2 open and the Oct 19 close. Not investment advice.